About this document "BRAF V600E testing": What other genetic tests could I consider
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Let me help explain additional genetic testing options that are typically recommended alongside BRAF V600E testing for colorectal cancer, based on current guidelines:
According to the NCCN Guidelines for Colorectal Cancer (2024):
- RAS (KRAS and NRAS) testing is considered essential and should be performed alongside BRAF testing for metastatic colorectal cancer
- MSI (Microsatellite Instability) or MMR (Mismatch Repair) testing is recommended for all colorectal cancer patients
The American Society of Clinical Oncology (ASCO) Guidelines recommend:
- Universal testing for Lynch Syndrome through MMR/MSI testing for all colorectal cancer patients
- Comprehensive biomarker testing including: • RAS mutations (KRAS, NRAS) • HER2 amplification testing, particularly in RAS/BRAF wild-type cases • NTRK fusion testing
The National Cancer Institute (NCI) also notes that comprehensive molecular testing may include:
- PIK3CA mutation testing
- Tumor mutational burden (TMB) assessment
- Other emerging biomarkers as part of next-generation sequencing panels
Important note: Please discuss with your oncologist which specific tests are most appropriate for your situation, as testing recommendations can vary based on your specific cancer stage, type, and treatment goals.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with diagnosis for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ